Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Apr;10(2):109-16.
doi: 10.1159/000376594.

Hyperthermia Is Now Included in the NCCN Clinical Practice Guidelines for Breast Cancer Recurrences: An Analysis of Existing Data

Vassilis Kouloulias  1 , Sotiria Triantopoulou  2 , Nikolaos Uzunoglou  3 , Kyriaki Pistevou-Gompaki  4 , Alfred Barich  5 , Anna Zygogianni  2 , George Kyrgias  6 , Dimitris Kardamakis  7 , Dimitris Pectasidis  8 , John Kouvaris  2 ; Greek Society of Hyperthermic Oncology
Affiliations

Hyperthermia Is Now Included in the NCCN Clinical Practice Guidelines for Breast Cancer Recurrences: An Analysis of Existing Data

Vassilis Kouloulias et al. Breast Care (Basel). 2015 Apr.

Abstract

Background: Hyperthermia has been included in the 2013 National Comprehensive Cancer Network (NCCN) guidelines as an option for the treatment of breast recurrences. The purpose of this article is to demonstrate the important role of hyperthermia as a therapeutic modality by presenting clinical trials on this subject carried out in the last decades.

Materials and methods: All relevant trials published since 1987 were retrieved from Medline and reviewed.

Results: Results show that the addition of hyperthermia to radiotherapy and/or chemotherapy for the treatment of breast cancer enhances treatment response and can increase local control.

Conclusion: Further studies are required to evaluate potential benefits of hyperthermia in the treatment of other kinds of superficial tumors.

Keywords: Breast cancer recurrences; Clinical trials; Hyperthermia; Radiotherapy.

PubMed Disclaimer

References

    1. Guarneri V, Conte PF. The curability of breast cancer and the treatment of advanced disease. Eur J Nucl Med Mol Imaging. 2004;31:149–161. - PubMed
    1. Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN. Overview of resistance to systemic therapy in patients with breast cancer. Adv Exp Med Biol. 2007;608:1–22. - PubMed
    1. Cance WG, Carey LA, Calvo BF, Sartor C, Sawyer L, Moore DT, Rosenman J, Ollila DW, Graham M., 2nd Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival. Ann Surg. 2002;236:295–303. - PMC - PubMed
    1. Zagar TM, Oleson JR, Vujaskovic Z, Dewhirst MW, Craciunescu OI, Blackwell KL, Prosnitz LR, Jones EL. Hyperthermia combined with radiation therapy for superficial breast cancer and chest wall recurrence: a review of the randomised data. Int J Hyperthermia. 2010;26:612–617. - PMC - PubMed
    1. Wang H, Li X, Xi X, Hu B, Zhao L, Liao Y, Tang J. Effects of magnetic induction hyperthermia and radiotherapy alone or combined on a murine 4T1 metastatic breast cancer model. Int J Hyperthermia. 2011;27:563–572. - PubMed

LinkOut - more resources